Affiliation:
1. APA 2009 Organizing Committee, Diagnostic and Experimental Medicine, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Abstract
The 5th annual Applied Pharmaceutical Analysis (APA) Conference recently convened in Boston, affording a unique opportunity for analytical scientists and pharmaceutical opinion leaders to exchange ideas on subjects related to drug disposition. The theme for this year’s meeting, The Role of Bioanalysis and Absorption, Distribution, Metabolism, and Excretion in Translational Medicine, was evident throughout the sessions. Consistent with past meetings, the sessions were grouped into three workshops representing different areas of focus: regulated bioanalysis, biotransformation and discovery. A total of 68 talks were presented at APA 2009, along with nine posters. While MS was the main analytical tool represented, several ligand-binding applications were also presented, consistent with the current industry trend towards protein biomarkers and biotherapeutics. Overall, the meeting attracted 290 attendees, which represents an 8% increase from 2008. The affiliation of attendees was as follows: pharmaceutical and biotechnology (61%), contract research organization (24%), vendor (12%) and academics or government (3%).
Subject
Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry
Reference6 articles.
1. Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations
2. US FDA.Guidance for Drug Evaluation and Research.Guidance for industry: safety testing for drug metabolites. US FDA, MD, USA, February 2008.
3. European Medicines Agency.Bioanalysis Guidance: Concept Paper/Recommendations on the Need for a (CHMP) Guideline on The Validation of Bioanalytical Methods. EMEA, London, UK, December 2008.
4. Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
5. US FDA.Guidance for Drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation. US FDA, MD, USA, May 2001.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献